☆ 4.6 Letter

Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 157, Issue 2, Pages 270-274

Publisher

WILEY-BLACKWELL

DOI: 10.1111/j.1365-2141.2011.08964.x

Keywords

MIR29B; acute promyelocytic leukaemia; neutrophil differentiation; PU; 1 (SPI1); MYC

Categories

Hematology

Funding

NHLBI NIH HHS [R01HL091219] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Biochemistry & Molecular Biology

HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia

Sebastian Gregoricchio, Lelia Polit, Michela Esposito, Jeremy Berthelet, Laure Delestre, Emilie Evanno, M'Boyba Diop, Isabelle Gallais, Hanna Aleth, Mathilde Poplineau, Wilbert Zwart, Frank Rosenbauer, Fernando Rodrigues-Lima, Estelle Duprez, Valentina Boeva, Christel Guillouf

Summary: This study reveals the mechanism of transcriptional repression by SPI1 in the erythroid lineage, involving complex functional connections between SPI1 and the epigenetic regulators HDAC1 and PRC2.

NUCLEIC ACIDS RESEARCH (2022)

Add to Collection

Review Chemistry, Medicinal

Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia

Chengyuan Liang, Guaiping Qiao, Yuzhi Liu, Lei Tian, Nan Hui, Juan Li, Yuling Ma, Han Li, Qianqian Zhao, Wenqiang Cao, Hong Liu, Xiaodong Ren

Summary: All-trans-retinoic acid (ATRA) is effective in preventing cancer and treating skin diseases and acute promyelocytic leukaemia (APL) by regulating differentiation-related gene transcription and autophagy through inhibiting mTOR. A total of 68 ATRA analogues show promising antitumour therapeutic potential for further development and research.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Immunology

Extracellular Traps Increase Burden of Bleeding by Damaging Endothelial Cell in Acute Promyelocytic Leukaemia

Yufeng Wang, Chunxu Wang, Nan Zuo, Hao Yang, Shaohong Fang, Jialan Shi

Summary: This study investigates the role of ETs in endothelial injury in APL and suggests that targeting ETs production may be an effective approach for relieving vascular leakage and reducing the burden of bleeding.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Hematology

Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters

Carmelo Gurnari, Massimo Breccia, Francesca Di Giuliano, Emilia Scalzulli, Mariadomenica Divona, Alfonso Piciocchi, Laura Cicconi, Eleonora De Bellis, Adriano Venditti, Maria Ilaria Del Principe, William Arcese, Francesco Lo-Coco, Francesco Garaci, Maria Teresa Voso

Summary: Patients with acute promyelocytic leukaemia (APL) who experience intracranial haemorrhage (ICH) are typically older and more likely to have high-risk APL. Positivity for the 'swirl' sign and hydrocephalus on neuroradiological imaging are predictors of a fatal outcome.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Cell Biology

PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia

Xi Xu, Wenwen Zhang, Li Xuan, Yanhui Yu, Wen Zheng, Fang Tao, Jacqelyn Nemechek, Chong He, Weiwei Ma, Xue Han, Siyu Xie, Minyi Zhao, Jian Wang, Yuhua Qu, Qifa Liu, John M. Perry, Linjia Jiang, Meng Zhao

Summary: “T cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy. In this study, a rare inhibitory receptor called programmed cell death 1 (PD-1) was identified as a marker for leukemia stem cells (LSCs) in T-ALL. Blocking PD-1 significantly eradicated LSCs and suppressed disease progression, and combination therapy with PD-1 blockade and chemotherapy extended survival. Mechanistically, PD-1+ LSCs had high NOTCH1-MYC activity and were protected against apoptosis. These findings provide a therapeutic approach for eliminating LSCs in T-ALL.”

NATURE CELL BIOLOGY (2023)

Add to Collection

Article Oncology

Effects of MYC Inhibitors on the Growth of Acute Leukaemia Cells

Kotomi Noguchi, Mai Itoh, Chisuzu Ito, Shuji Tohda

Summary: In this study, the effects of MYC inhibitors on acute leukaemia cell lines were examined. It was found that these inhibitors suppressed cell growth and regulated the expression of various signaling proteins and transcription factors. They also showed potential in targeting NOTCH1-mutated T-ALL.

ANTICANCER RESEARCH (2023)

Add to Collection

Article Cell Biology

The role of E2A in ATPR-induced cell differentiation and cycle arrest in acute myeloid leukaemia cells

Meiju Zhang, Long-fei Wang, Xiaoling Xu, Yan Du, Lanlan Li, Ge Deng, Yubin Feng, Ziyao Ou, Ke Wang, Yayun Xu, Xiaoqing Peng, Feihu Chen

Summary: Acute myeloid leukaemia (AML) is a disease with poor prognosis and requires novel therapeutic approaches. This study found that ATPR could inhibit cell differentiation and cell cycle in AML by inhibiting the expression and activity of the E2A gene and activating the P53 pathway.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

Add to Collection

Article Oncology

SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia

Courtney Chambers, Katerina Cermakova, Yuen San Chan, Kristen Kurtz, Katharina Wohlan, Andrew Henry Lewis, Christiana Wang, Anh Pham, Milan Dejmek, Michal Sala, Mario Loeza Cabrera, Rogelio Aguilar, Radim Nencka, H. Daniel Lacorazza, Rachel E. Rau, H. Courtney Hodges

Summary: In acute myeloid leukemia (AML), SWI/SNF chromatin remodeling complexes sustain leukemic identity by driving high levels of MYC. PU.1 binds to most of its targets in a SWI/SNF-independent manner and recruits SWI/SNF to promote accessibility for other AML core regulatory factors. SWI/SNF inhibition induces therapeutic response in AML but also impairs PU.1-dependent B-cell and monocyte populations, revealing the on-and off-tumor effects of SWI/SNF blockade.

CANCER RESEARCH (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genes

Yoshiro Hirasaki, Atsushi Okabe, Masaki Fukuyo, Bahityar Rahmutulla, Yasunobu Mano, Motoaki Seki, Takayuki Hoshii, Takao Namiki, Atsushi Kaneda

Summary: This study found that cinobufagin can induce apoptosis in human acute myeloid leukaemia cells and has inhibitory effects on c-Myc. Transcriptomic analysis and gene set enrichment analysis further revealed its mechanisms of action.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Add to Collection

Article Immunology

NEAT1/microRNA 339-5p/SPI1 Axis Feedback Loop Contributes to Osteogenic Differentiation in Acute Suppurative Osteomyelitis in Children

Dongsheng Zhu, Zhitao Zhu, Han Qi

Summary: This study revealed for the first time that the NEAT1-miR-339-5p-SPI1 feedback loop promotes osteogenic differentiation in hBMSCs and sheds new light on the role of NEAT1 during this process.

JOURNAL OF INFLAMMATION RESEARCH (2023)

Add to Collection

Article Pharmacology & Pharmacy

Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation

Xibao Yu, Xin Liu, Xuan Liu, Shuang Jin, Mengjun Zhong, Dingrui Nie, Xiangbo Zeng, Xianfeng Wang, Jiaxiong Tan, Yangqiu Li, Chengwu Zeng

Summary: CASP1/GSDMD expression is lower in patients with acute promyelocytic leukemia (APL) and most other subtypes of primary de novo acute myeloid leukemia (AML), but is increased in all-trans-retinoic acid (ATRA)-treated APL cells; ATRA induces CASP1 expression via the IFN gamma/STAT1 pathway and triggers pyroptotic cell death and differentiation in APL cells, serving as a suppressor in APL progression.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Add to Collection

Review Oncology

Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia

Uday Kulkarni, Vikram Mathews

Summary: Treatment for acute promyelocytic leukemia has transformed from being the most malignant form of acute leukemia to one with excellent long term survival rates over the past three decades. Current treatment regimens for APL incorporate minimal chemotherapeutic drugs, with a potential future shift towards completely oral arsenic trioxide + ATRA regimen for low-intermediate risk cases. For high-risk cases, minimal anthracycline use with ATO + ATRA might become the standard of care soon. Promising non-chemotherapy drugs are being explored for high risk and relapsed cases, with a potential to translate to a complete oral chemotherapy free combination regimen in the future.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases

Lynn Chin, Cyrus R. Kumana, Yok-Lam Kwong, Harinder Gill

Summary: Appreciation of the properties of arsenic trioxide (ATO) has revolutionized the treatment of acute promyelocytic leukaemia (APL) and holds promise for numerous other diseases. ATO's ability to counteract the effects of the oncoprotein PML::RARA, found in APL patients, has made it a curative treatment when combined with all-trans retinoic acid. Additionally, ATO's multiple mechanisms of action have opened up possibilities for its use in various autoimmune or inflammatory disorders, solid organ tumors, lymphomas, and other subtypes of AML. The development of oral ATO has improved treatment convenience and accessibility.

PHARMACEUTICS (2022)

Add to Collection

Article Multidisciplinary Sciences

Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia

William Villiers, Audrey Kelly, Xiaohan He, James Kaufman-Cook, Abdurrahman Elbasir, Halima Bensmail, Paul Lavender, Richard Dillon, Borbala Mifsud, Cameron S. Osborne

Summary: The PML-RARA gene fusion is the characteristic driver of Acute Promyelocytic Leukaemia (APL) and is known to bind to the genome. Here, the authors characterise the impact of PML-RARA on gene regulation in APL cell lines and patient samples using transcriptomics, epigenomics, and machine learning.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Hematology

Management of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimens

N. A. Fouzia, Vibhor Sharma, Saravanan Ganesan, Hamenth K. Palani, Nithya Balasundaram, Sachin David, Uday P. Kulkarni, Anu Korula, Anup J. Devasia, Sukesh C. Nair, Nancy Beryl Janet, Aby Abraham, Thenmozhi Mani, Jeyaseelan Lakshmanan, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews

Summary: The study showed that in relapsed APL patients, obtaining a second molecular remission after salvage therapy was more common. Autologous stem cell transplant was found to be an effective option for patients achieving MR, leading to improved long-term survival rates.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Review Virology

Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics

Shentian Zhuang, Bruce E. Torbett

Summary: This paper reviews the interplay between the HIV-1 capsid and host factors during early stages of viral replication, highlighting the structure of the capsid, host factor interactions, and screening techniques. Understanding these interactions can inform HIV-1 pathogenesis and the development of capsid-centric antiretroviral therapeutics. The discovery of the capsid-targeting inhibitor GS-6207 represents a significant advancement in this field.

VIRUSES-BASEL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy

Magali Humbert, Kristina Seiler, Severin Mosimann, Vreni Rentsch, Katyayani Sharma, Amit Pandey, Sharon L. McKenna, Mario P. Tschan

Summary: The study found that FASN mRNA levels were significantly higher in acute myeloid leukemia (AML) patients compared to healthy granulocytes or hematopoietic progenitors. Inhibition of FASN expression levels accelerated differentiation of APL cell lines and re-sensitized ATRA refractory non-APL AML cells. FASN reduction promoted translocation of transcription factor EB (TFEB) to the nucleus, leading to activation of CLEAR network genes and lysosomal biogenesis.

CELL DEATH AND DIFFERENTIATION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Discrimination between Functional and Non-functional Cellular Gag Complexes involved in HIV-1 Assembly

Yisong Deng, John A. Hammond, Raymond Pauszek, Stosh Ozog, Ilean Chai, Jessica Rabuck-Gibbons, Rajan Lamichhane, Scott C. Henderson, David P. Millar, Bruce E. Torbett, James R. Williamson

Summary: Most GCC species are mainly composed of monomeric or dimeric Gag molecules bound to ribosomal complexes, representing a population of Gag not yet functionally committed for incorporation into viable virion precursors. A subset of large GCC complexes, with more than 20 Gag molecules, may be equivalent to membrane-associated puncta as genuine assembling-virus intermediates. These findings provide a rationale for the existence of diverse GCCs and lay the foundation for characterizing on-pathway intermediates in early virus assembly.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution

Christian M. Gallardo, Shiyi Wang, Daniel J. Montiel-Garcia, Susan J. Little, Davey M. Smith, Andrew L. Routh, Bruce E. Torbett

Summary: This study overcomes technical challenges in RNA virus sequencing by developing a nanopore-based method to accurately sequence viral genomes from clinical samples. The method can detect rare viral genomes at <1% frequency, facilitating the study of genetic resistance to antiviral therapy and immune pressure.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Increased LAMP2A levels correlate with a shorter disease-free survival of HER2 negative breast cancer patients and increased breast cancer cell viability

Igor Tokarchuk, Felice A. Janser, Anna M. Schlafli, Marta Teixeira Pinto, Magali Humbert, Nicolas J. Niklaus, Sabina Berezowska, Rupert Langer, Mario P. Tschan

Summary: High expression of LAMP2A is associated with worse disease-free survival in breast cancer patients with HER2 negative tumors and serves as an independent prognostic parameter. Low levels of LAMP2A can reduce proliferation of breast cancer cell lines.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Medicine, Research & Experimental

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer

Zhang Yang, Shun-Qing Liang, Maria Saliakoura, Haitang Yang, Eric Vassella, Georgia Konstantinidou, Mario Tschan, Balazs Hegedus, Liang Zhao, Yanyun Gao, Duo Xu, Haibin Deng, Thomas M. Marti, Gregor J. Kocher, Wenxiang Wang, Ralph A. Schmid, Ren-Wang Peng

Summary: By combining FGFR1 and PLK1 inhibitors, synergistic cytotoxicity can be achieved in KRAS-mutant tumors, inducing cell death. This treatment induces apoptosis by upregulating ROS and activating the JNK/p38 pathway, while enhancing sensitivity of tumor cells to inhibitors by inhibiting autophagy.

EMBO MOLECULAR MEDICINE (2021)

Add to Collection

Review Oncology

Lysosomes in acute myeloid leukemia: potential therapeutic targets?

Sreoshee Rafiq, Sharon L. McKenna, Sylviane Muller, Mario P. Tschan, Magali Humbert

Summary: Lysosomes, traditionally known for degrading cellular macromolecules, have emerged as crucial regulators of cell homeostasis. Their involvement in cellular trafficking, nutrient signaling, energy metabolism, and immune regulation has sparked interest in targeting lysosomes for novel disease treatments, particularly cancer. This review highlights the diverse functions of lysosomes and their importance in malignant disease, with a focus on potential targeting strategies in acute myeloid leukemia (AML).

LEUKEMIA (2021)

Add to Collection

Review Cell Biology

The Multifaceted Functions of Autophagy in Breast Cancer Development and Treatment

Nicolas J. Niklaus, Igor Tokarchuk, Mara Zbinden, Anna M. Schlafli, Paola Maycotte, Mario P. Tschan

Summary: Autophagy is a complex catabolic process that plays a crucial role in maintaining cellular homeostasis and preventing cancer by clearing damaged organelles and molecules. Breast cancer, with its high heterogeneity, poses challenges for long-term survival due to aggressive recurrence.

CELLS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Covariation of viral recombination with single nucleotide variants during virus evolution revealed by CoVaMa

Shiyi Wang, Stephanea L. Sotcheff, Christian M. Gallardo, Elizabeth Jaworski, Bruce E. Torbett, Andrew L. Routh

Summary: Viruses adapt to their environments through acquiring new single-nucleotide variants (SNVs) and recombination events. However, studying the correlation between recombination events and SNVs has been challenging due to genetic complexity and lack of tools. This study improved a pipeline to measure linkage disequilibrium between recombination events and SNVs, and revealed their role in viral evolution.

NUCLEIC ACIDS RESEARCH (2022)

Add to Collection

Article Cell Biology

Role of cardiolipins, mitochondria, and autophagy in the differentiation process activated by all-trans retinoic acid in acute promyelocytic leukemia

Maurizio Gianni, Laura Goracci, Anna Schlaefli, Alessandra Di Veroli, Mami Kurosaki, Luca Guarrera, Marco Bolis, Marika Foglia, Monica Lupi, Mario P. Tschan, Gabriele Cruciani, Mineko Terao, Enrico Garattini

Summary: This study investigates the role of lipids in the process of granulocytic differentiation activated by all-trans retinoic acid (ATRA) in Acute-Promyelocytic-Leukemia (APL) blasts. Using the NB4 cell-line as a model, the study found that exposure to ATRA resulted in a reduction in cardiolipin levels, leading to mitochondrial dysfunction and inhibition of granulocytic differentiation.

CELL DEATH & DISEASE (2022)

Add to Collection

Article Cell Biology

Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions

Kristina Seiler, Magali Humbert, Petra Minder, Iris Mashimo, Anna M. Schlafli, Deborah Krauer, Elena A. Federzoni, Bich Vu, James J. Moresco, John R. Yates, Martin C. Sadowski, Ramin Radpour, Thomas Kaufmann, Jean-Emmanuel Sarry, Joern Dengjel, Mario P. Tschan, Bruce E. Torbett

Summary: This study found that HK3 is dispensable for glycolytic activity in AML cells while promoting cell survival, possibly through direct interaction with the BH3-only protein BIM during ATRA-induced neutrophil differentiation.

CELL DEATH & DISEASE (2022)

Add to Collection

Article Hematology

Assessment of safety and immunogenicity of MHC homozygous iPSC-derived CD34+hematopoietic progenitors in an NHP model

Saritha S. D'Souza, Akhilesh Kumar, John Maufort, Jason T. Weinfurter, Matthew Raymond, Nick S. Strelchenko, Elizabeth Perrin, Jennifer Coonen, Andres Mejia, Heather A. Simmons, Bruce E. Torbett, Matthew Reynolds, James A. Thomson, Igor I. Slukvin

Summary: The administration of ex vivo expanded somatic myeloid progenitors is explored as a way to accelerate myeloid recovery. Recent studies have shown the potential of hematopoietic progenitors derived from MHC homozygous iPSCs in treating cytopenia with good tolerance and safety in experimental animals.

BLOOD ADVANCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Selective ablation of 3′ RNA ends and processive RTs facilitate direct cDNA sequencing of full-length host cell and viral transcripts

Christian M. Gallardo, Anh-Viet T. Nguyen, Andrew L. Routh, Bruce E. Torbett

Summary: Alternative splicing is important for viral proliferation and gene expression regulation. Traditional RNA-seq methods have limitations in coverage, while the CASPR method allows simultaneous analysis of viral and host cell transcripts, improving coverage and detection of long transcripts.

NUCLEIC ACIDS RESEARCH (2022)

Add to Collection

Article Biology

ViReMa: a virus recombination mapper of next-generation sequencing data characterizes diverse recombinant viral nucleic acids

Stephanea Sotcheff, Yiyang Zhou, Jason Yeung, Yan Sun, John E. Johnson, Bruce E. Torbett, Andrew L. Routh

Summary: Genetic recombination is important for viruses to adapt to new environments. However, detecting recombination events in high-throughput sequencing data is challenging due to the diverse nature of these events. In this study, the algorithm ViReMa was updated to accurately detect recombination events in longer reads and provide standardized output reports for multiple types of recombinant species.

GIGASCIENCE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.